SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. Cortey, A. Mailloux, S. Huguet-Jacquot, V. Castaigne-Meary, G. Macé, A. N’Guyen, M. Berry, F. Pernot, J.-C. Galiay, F. Lattes, B. Blanchard, B. Carbonne, Incompatibilidad eritrocítica maternofetal, EMC - Pediatría, 2012, 47, 4, 1

    CrossRef

  2. 2
    A. Cortey, A. Mailloux, S. Huguet-Jacquot, V. Castaigne-Meary, G. Macé, A. N’Guyen, M. Berry, F. Pernot, J.-C. Galiay, F. Lattes, B. Blanchard, B. Carbonne, Incompatibilités fœtomaternelles érythrocytaires, EMC - Pédiatrie - Maladies infectieuses, 2012, 7, 3, 1

    CrossRef

  3. 3
    I.Z. MacKenzie, Susan Dutton, Fenella Roseman, Evidence to support the single-dose over the two-dose protocol for routine antenatal anti-D Rhesus prophylaxis: a prospective observational study, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011, 158, 1, 42

    CrossRef

  4. 4
    J. Davies, R. Chant, S. Simpson, R. Powell, Routine antenatal anti-D prophylaxis – is the protection adequate?, Transfusion Medicine, 2011, 21, 6
  5. 5
    JM Koelewijn, M de Haas, TGM Vrijkotte, CE van der Schoot, GJ Bonsel, Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis, BJOG: An International Journal of Obstetrics & Gynaecology, 2009, 116, 10
  6. 6
    A. Benachi, I. Nisand, Immunoglobulines Anti-D prophylactiques aux femmes RhD- en France: une recommandation précipitée?, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2007, 36, 6, 523

    CrossRef

  7. 7
    B. Chaffe, J. Ford, V. Bills, Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen, Transfusion Medicine, 2007, 17, 5